News, 2012

August 27, 2012

Registration of Dihydroquercetin as the pharmaceutical substance

Dihydroquercetin produced by Ametis JSC is registered as pharmaceutical substance (PS-000388).


May, 2012

Third place in the annual competition “The best organization of the industrial safety measures among the enterprises”

Ametis JSC was awarded the third place in the annual competition “The best organization of the industrial safety measures among the enterprises of Blagoveshchensk city” for its business activities in 2011.


April, 2012

Ametis JSC is among the winners of the investment competition «Annual Public Award- Regions — Sustainable Development»

Ametis JSC is among the winners of the investment competition «Annual Public Award- Regions — Sustainable Development» Ametis JSC is among the winners of the investment competition «Annual Public Award- Regions — Sustainable Development» with the project «Reconstruction of the Main Industrial Building for the Manufacturing of the Pharmaceutical Substances Arabinogalactan, Dihydroquercetin, and the Medicinal Preparation Created from Them». More than 950 enterprises from 78 Russian regions, including 277 industrial projects, participated in the competition. Twenty-six investment projects from 15 Russian regions were among the winners.


March 11-15, 2012

Participation in the Annual Meeting of the Society of Toxicology

A poster on the safety and efficacy of Larch tree-derived dihydroquercetin, manufactured by Ametis, JCS was presented on the 51st Annual Meeting of the Society of Toxicology (SOT), held in San Francisco, California, from March 11-15, 2012. Alexander Schauss, PhD, FACN- the Senior Director of AIBMR, John R, Endres, ND- the Chief Scientific Officer, and Inna Yegorova, PhD, N.D., M.S.G.- the Exclusive Representative of Ametis in North America have attended the 51st Annual Meeting of the Society of Toxicology (SOT), held in San Francisco, California, from March 11-15, 2012, to present a poster on the safety and efficacy of Larch tree-derived dihydroquercetin, manufactured by Ametis, JCS. 2012 SOT is the premier international event in toxicology - the largest gathering of toxicologists in the world. The meeting had an attendance of 7,300 scientists, providing attendees with over 3,000 presentations, nearly 200 sessions, and 344 visiting exhibitors. At the meeting, the poster "Safety Assessment of Larch-derived Dihydroquercetin" was presented in the section on radioprotection. The poster generated a lot of interest among the attendees. The abstract of the poster was published in the proceedings of the Society of Toxicology- Schauss, A.G., Yergorova, I., and Endres, J. Larch tree-derived oral dihydroquercitin (DHQ) supplementation as a natural radioprotective agent. Toxicological Sciences, 2012; 126 (suppl 1): S45. Toxicological Sciences is published by Oxford Journals.